ECSP066482A - Uso de tigeciclina sola o en combinación con rifampicina para tratar la osteomielitis y/o la artritis séptica - Google Patents

Uso de tigeciclina sola o en combinación con rifampicina para tratar la osteomielitis y/o la artritis séptica

Info

Publication number
ECSP066482A
ECSP066482A EC2006006482A ECSP066482A ECSP066482A EC SP066482 A ECSP066482 A EC SP066482A EC 2006006482 A EC2006006482 A EC 2006006482A EC SP066482 A ECSP066482 A EC SP066482A EC SP066482 A ECSP066482 A EC SP066482A
Authority
EC
Ecuador
Prior art keywords
joint
infection
combination
infections
bone
Prior art date
Application number
EC2006006482A
Other languages
English (en)
Inventor
Raymond Thomas Testa
Jason Calhoun
Joh T Mader
Original Assignee
Univ Texas
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Wyeth Corp filed Critical Univ Texas
Publication of ECSP066482A publication Critical patent/ECSP066482A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Glass Compositions (AREA)

Abstract

La presente invención está dirigida a un método para el tratamiento de infecciones de hueso o médula ósea, infección de la articulación o infección de los tejidos circundantes a la articulación por la administración del antibiótico tigeciclina sola o en combinación con un antibiótico de rifamicina. En una realización de preferencia, la infección de hueso o de médula ósea causa osteomielitis. En otra realización, la infección articular o infección de los tejidos circundantes causa artritis séptica. La invención también está dirigida a la fabricación de un medicamento para el tratamiento de infecciones de hueso y/o médula ósea, o infecciones articulares y/o infecciones en los tejidos circundantes a la articulación con tigeciclina sola o en combinación con rifampicina.
EC2006006482A 2003-09-05 2006-04-04 Uso de tigeciclina sola o en combinación con rifampicina para tratar la osteomielitis y/o la artritis séptica ECSP066482A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50047403P 2003-09-05 2003-09-05
US10/933,455 US20050148553A1 (en) 2003-09-05 2004-09-03 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Publications (1)

Publication Number Publication Date
ECSP066482A true ECSP066482A (es) 2006-11-24

Family

ID=36283191

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006482A ECSP066482A (es) 2003-09-05 2006-04-04 Uso de tigeciclina sola o en combinación con rifampicina para tratar la osteomielitis y/o la artritis séptica

Country Status (24)

Country Link
US (1) US20050148553A1 (es)
EP (1) EP1663233B1 (es)
JP (1) JP2007504249A (es)
KR (1) KR20060072135A (es)
CN (1) CN1889957A (es)
AT (1) ATE401888T1 (es)
AU (1) AU2004270231A1 (es)
BR (1) BRPI0413770A (es)
CA (1) CA2537281A1 (es)
CO (1) CO5690590A2 (es)
DE (1) DE602004015307D1 (es)
DK (1) DK1663233T3 (es)
EC (1) ECSP066482A (es)
ES (1) ES2311860T3 (es)
HK (1) HK1091754A1 (es)
IL (1) IL173878A0 (es)
MX (1) MXPA06002414A (es)
NO (1) NO20061468L (es)
PL (1) PL1663233T3 (es)
PT (1) PT1663233E (es)
RU (1) RU2329047C2 (es)
SI (1) SI1663233T1 (es)
UA (1) UA83250C2 (es)
WO (1) WO2005023263A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8652001A1 (es) * 2004-11-05 2006-10-13 Wyeth Corp Metabolitos glucuronidos de tigeciclina y epimeros de los mismos
GT200600112A (es) 2005-03-14 2006-11-29 Composiciiones de tigeciclina y metodos de preparacion
CA2632213A1 (en) * 2005-12-22 2007-07-05 Wyeth Oral formulations comprising tigecycline
CA2631632A1 (en) * 2005-12-22 2007-07-05 Wyeth Methods of treating gastrointestinal tract infections with tigecycline
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
US20120115778A1 (en) * 2009-07-15 2012-05-10 The Trustees Of Columbia University In The City Of New York Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2
WO2011109899A1 (en) * 2010-03-10 2011-09-15 University Health Network Use of tigecycline for treatment of cancer
RU2454252C1 (ru) * 2010-12-29 2012-06-27 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава) Способ профилактики гнойно-септических осложнений (гсо) при операциях на толстой кишке
KR101626544B1 (ko) * 2013-08-07 2016-06-02 서울대학교산학협력단 프롤릴 히드록실라아제 저해제 또는 히스톤 탈아세틸라아제 저해제, 및 항생제를 포함하는 골질환의 예방 또는 치료용 약학적 조성물
WO2018039087A1 (en) * 2016-08-20 2018-03-01 Gregg John Malcolm Hall Antimicrobial drug methods of use & therapeutic compositions
CN112843071A (zh) * 2020-09-08 2021-05-28 天津国际生物医药联合研究院 土霉素或者替加环素在抗分枝杆菌感染中的潜在应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US6582719B2 (en) * 2001-02-02 2003-06-24 The Trustees Of Columbia University In The City Of New York Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
GB0114672D0 (en) * 2001-06-15 2001-08-08 Orthogenics As Pharmaceutical formulations and methods of medical treatment
EP2332550A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of neurodegenerative diseases
CA2490062A1 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith

Also Published As

Publication number Publication date
WO2005023263A1 (en) 2005-03-17
ES2311860T3 (es) 2009-02-16
EP1663233A1 (en) 2006-06-07
RU2006110936A (ru) 2007-10-10
DE602004015307D1 (de) 2008-09-04
NO20061468L (no) 2006-05-31
SI1663233T1 (sl) 2008-12-31
US20050148553A1 (en) 2005-07-07
PT1663233E (pt) 2008-10-15
AU2004270231A1 (en) 2005-03-17
IL173878A0 (en) 2006-07-05
CO5690590A2 (es) 2006-10-31
DK1663233T3 (da) 2008-11-10
ATE401888T1 (de) 2008-08-15
MXPA06002414A (es) 2006-08-31
HK1091754A1 (en) 2007-01-26
JP2007504249A (ja) 2007-03-01
PL1663233T3 (pl) 2009-05-29
CA2537281A1 (en) 2005-03-17
RU2329047C2 (ru) 2008-07-20
CN1889957A (zh) 2007-01-03
KR20060072135A (ko) 2006-06-27
UA83250C2 (ru) 2008-06-25
BRPI0413770A (pt) 2006-10-31
EP1663233B1 (en) 2008-07-23

Similar Documents

Publication Publication Date Title
ECSP066482A (es) Uso de tigeciclina sola o en combinación con rifampicina para tratar la osteomielitis y/o la artritis séptica
BRPI0508390B8 (pt) uso de um anticorpo antagonista anti-ngf, bem como kit e composição farmacêutica para tratamento de dor de câncer de osso
DK1420801T3 (da) Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis
BRPI0412404A (pt) uso de rapamicina e de derivado da rapamicina para o tratamento da perda óssea
CO7250441A2 (es) Inhibidores de girasa y uso de los mismos
MXPA03002576A (es) Metodos para tratar lesiones musculares.
DK1850774T3 (da) Engangsindretning til behandling af infektioner i menneskelemmer
PT1259512E (pt) Compostos de pteridin para o tratamento da psoriase
EA200800570A1 (ru) Фосфонированные рифамицины и их применение для профилактики и лечения костных и суставных инфекций
BR0311948A (pt) Macrociclos de amida antibacterianos
HUE041133T2 (hu) Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
BR0213154A (pt) Compostos de glicopeptìdeo - cefalosporina de ligação reticulada, composições farmacêuticas de tais compostos, método de fabricação dos mesmos e seus usos
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
EA200702311A1 (ru) Фосфонированные фторхинолоны, их антибактериальные аналоги и способы профилактики и лечения инфекций костей и суставов
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
BR0312470A (pt) Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto
NO20062229L (no) Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er)
BR0307085A (pt) Terapia combinada para o tratamento de infecções bacterianas
DK1648531T3 (da) Anvendelse af aseptiske aktive stoffer i PMMA-knoglecementer
GT200600331A (es) Inhibidores de 6-alquiliden-penem-beta-lactamasa biciclicos y combinacion de antibioticos de beta-lactama: un antibiotico de amplio espectro.
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
TW200518741A (en) Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
GT200600332A (es) Inhibidores de 6-alquiliden-penem beta-lactamasa triciclicos y combinación de antibióticos de b-lactama: un antibiotico de amplio espectro
DE60207884D1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren
CY1108472T1 (el) Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης